Article
Pfizer, Valneva to stop testing Lyme disease vaccine in some U.S. patients
Rating:
0.0
Views:
58
Likes:
1
Library:
1
Drugmaker Pfizer Inc and France's Valneva will stop testing a Lyme disease vaccine in roughly half of U.S. patients in a late-stage study, the companies said, citing a breach of clinical trial guidelines by a third-party contractor.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value